SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '087'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AJ6_A_NOVA1_1 (GYRASE) |
3u2k | DNA GYRASE SUBUNIT B (Staphylococcusaureus) | 9 / 9 | ASN A 54GLU A 58ASP A 81ARG A 84ILE A 86PRO A 87ALA A 98ILE A 102THR A 173 | 087 A 1 (-3.9A)087 A 1 (-3.4A)087 A 1 (-3.5A)087 A 1 (-3.8A)087 A 1 (-4.4A)087 A 1 (-4.3A)NoneNone087 A 1 ( 3.8A) | 0.49A | 1aj6A-3u2kA:28.1 | 1aj6A-3u2kA:48.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B) |
3u2k | DNA GYRASE SUBUNIT B (Staphylococcusaureus) | 10 / 12 | ASP A 57GLU A 58ASP A 81ARG A 84ILE A 86PRO A 87ASP A 89ILE A 102ARG A 144THR A 173 | MG A 234 ( 4.8A)087 A 1 (-3.4A)087 A 1 (-3.5A)087 A 1 (-3.8A)087 A 1 (-4.4A)087 A 1 (-4.3A)NoneNone087 A 1 (-2.5A)087 A 1 ( 3.8A) | 0.60A | 1kijA-3u2kA:26.9 | 1kijA-3u2kA:27.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B) |
3u2k | DNA GYRASE SUBUNIT B (Staphylococcusaureus) | 10 / 12 | ASN A 54GLU A 58ASP A 81ARG A 84ILE A 86PRO A 87ASP A 89ILE A 102ARG A 144THR A 173 | 087 A 1 (-3.9A)087 A 1 (-3.4A)087 A 1 (-3.5A)087 A 1 (-3.8A)087 A 1 (-4.4A)087 A 1 (-4.3A)NoneNone087 A 1 (-2.5A)087 A 1 ( 3.8A) | 0.61A | 1kijB-3u2kA:27.2 | 1kijB-3u2kA:27.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MJO_D_SAMD200_1 (METHIONINE REPRESSOR) |
3g6e | 50S RIBOSOMALPROTEIN L22P (Haloarculamarismortui) | 4 / 4 | HIS R 68ALA R 77PHE R 59GLY R 67 | A 02841 ( 3.3A) C 02087 ( 4.9A)None A 02841 ( 3.5A) | 1.15A | 1mjoD-3g6eR:undetectable | 1mjoD-3g6eR:21.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S14_A_NOVA1300_1 (TOPOISOMERASE IVSUBUNIT B) |
3u2k | DNA GYRASE SUBUNIT B (Staphylococcusaureus) | 11 / 12 | ASN A 54SER A 55ASP A 57GLU A 58ASP A 81ARG A 84PRO A 87ASP A 89ILE A 102ARG A 144THR A 173 | 087 A 1 (-3.9A)087 A 1 (-3.3A) MG A 234 ( 4.8A)087 A 1 (-3.4A)087 A 1 (-3.5A)087 A 1 (-3.8A)087 A 1 (-4.3A)NoneNone087 A 1 (-2.5A)087 A 1 ( 3.8A) | 0.53A | 1s14A-3u2kA:25.5 | 1s14A-3u2kA:43.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S14_B_NOVB2300_1 (TOPOISOMERASE IVSUBUNIT B) |
3u2k | DNA GYRASE SUBUNIT B (Staphylococcusaureus) | 11 / 12 | ASN A 54SER A 55ASP A 57GLU A 58ASP A 81ARG A 84PRO A 87ASP A 89ALA A 98ILE A 102ARG A 144 | 087 A 1 (-3.9A)087 A 1 (-3.3A) MG A 234 ( 4.8A)087 A 1 (-3.4A)087 A 1 (-3.5A)087 A 1 (-3.8A)087 A 1 (-4.3A)NoneNoneNone087 A 1 (-2.5A) | 0.56A | 1s14B-3u2kA:27.7 | 1s14B-3u2kA:43.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZZN_B_SAMB402_0 (UNCHARACTERIZEDPROTEIN MJ0883) |
3u2k | DNA GYRASE SUBUNIT B (Staphylococcusaureus) | 5 / 12 | TYR A 63ARG A 144GLY A 83ILE A 209ASN A 65 | None087 A 1 (-2.5A)NoneNone MG A 2 ( 4.7A) | 1.09A | 2zznB-3u2kA:undetectable | 2zznB-3u2kA:20.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BJW_A_SVRA508_2 (PHOSPHOLIPASE A2) |
3ph2 | CYTOCHROME C6 (Phormidiumlaminosum) | 5 / 9 | VAL B 52VAL B 51GLY B 55LYS B 56GLY B 64 | IMD B1088 (-4.5A)IMD B1088 (-4.3A)IMD B1088 ( 4.4A)HEM B1087 (-2.8A)None | 1.18A | 3bjwG-3ph2B:undetectable | 3bjwG-3ph2B:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_A_TFPA202_1 (PROTEIN S100-A4) |
3ph2 | CYTOCHROME C6 (Phormidiumlaminosum) | 5 / 12 | LEU B 37ILE B 48LEU B 79ASP B 80PHE B 11 | NoneHEM B1087 ( 4.4A)NoneNoneNone | 1.20A | 3ko0A-3ph2B:undetectable3ko0B-3ph2B:undetectable3ko0C-3ph2B:undetectable3ko0D-3ph2B:undetectable | 3ko0A-3ph2B:19.003ko0B-3ph2B:19.003ko0C-3ph2B:19.003ko0D-3ph2B:19.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_I_TFPI202_1 (PROTEIN S100-A4) |
3ph2 | CYTOCHROME C6 (Phormidiumlaminosum) | 5 / 12 | PHE B 11LEU B 37ILE B 48LEU B 79ASP B 80 | NoneNoneHEM B1087 ( 4.4A)NoneNone | 1.19A | 3ko0G-3ph2B:undetectable3ko0H-3ph2B:undetectable3ko0I-3ph2B:undetectable3ko0J-3ph2B:undetectable | 3ko0G-3ph2B:19.003ko0H-3ph2B:19.003ko0I-3ph2B:19.003ko0J-3ph2B:19.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_J_TFPJ202_1 (PROTEIN S100-A4) |
3ph2 | CYTOCHROME C6 (Phormidiumlaminosum) | 5 / 11 | PHE B 11LEU B 79ASP B 80LEU B 37ILE B 48 | NoneNoneNoneNoneHEM B1087 ( 4.4A) | 1.22A | 3ko0A-3ph2B:undetectable3ko0B-3ph2B:undetectable3ko0I-3ph2B:undetectable3ko0J-3ph2B:undetectable | 3ko0A-3ph2B:19.003ko0B-3ph2B:19.003ko0I-3ph2B:19.003ko0J-3ph2B:19.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_K_TFPK202_1 (PROTEIN S100-A4) |
3ph2 | CYTOCHROME C6 (Phormidiumlaminosum) | 5 / 12 | LEU B 37ILE B 48LEU B 79ASP B 80PHE B 11 | NoneHEM B1087 ( 4.4A)NoneNoneNone | 1.18A | 3ko0K-3ph2B:undetectable3ko0L-3ph2B:undetectable3ko0S-3ph2B:undetectable3ko0T-3ph2B:undetectable | 3ko0K-3ph2B:19.003ko0L-3ph2B:19.003ko0S-3ph2B:19.003ko0T-3ph2B:19.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_L_TFPL202_1 (PROTEIN S100-A4) |
3ph2 | CYTOCHROME C6 (Phormidiumlaminosum) | 5 / 12 | LEU B 79ASP B 80LEU B 37ILE B 48PHE B 11 | NoneNoneNoneHEM B1087 ( 4.4A)None | 1.15A | 3ko0K-3ph2B:undetectable3ko0L-3ph2B:undetectable3ko0M-3ph2B:undetectable3ko0N-3ph2B:undetectable | 3ko0K-3ph2B:19.003ko0L-3ph2B:19.003ko0M-3ph2B:19.003ko0N-3ph2B:19.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KO0_M_TFPM202_1 (PROTEIN S100-A4) |
3ph2 | CYTOCHROME C6 (Phormidiumlaminosum) | 5 / 12 | LEU B 37ILE B 48LEU B 79ASP B 80PHE B 11 | NoneHEM B1087 ( 4.4A)NoneNoneNone | 1.20A | 3ko0M-3ph2B:undetectable3ko0N-3ph2B:undetectable3ko0O-3ph2B:undetectable3ko0P-3ph2B:undetectable | 3ko0M-3ph2B:19.003ko0N-3ph2B:19.003ko0O-3ph2B:19.003ko0P-3ph2B:19.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LPS_A_NOVA901_1 (TOPOISOMERASE IVSUBUNIT B) |
3u2k | DNA GYRASE SUBUNIT B (Staphylococcusaureus) | 11 / 12 | ASN A 54SER A 55ASP A 57GLU A 58ASP A 81ARG A 84PRO A 87ASP A 89ILE A 102ARG A 144THR A 173 | 087 A 1 (-3.9A)087 A 1 (-3.3A) MG A 234 ( 4.8A)087 A 1 (-3.4A)087 A 1 (-3.5A)087 A 1 (-3.8A)087 A 1 (-4.3A)NoneNone087 A 1 (-2.5A)087 A 1 ( 3.8A) | 0.57A | 3lpsA-3u2kA:26.4 | 3lpsA-3u2kA:26.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4L3G_F_ACTF401_0 (METHYLAMINEDEHYDROGENASE HEAVYCHAIN) |
2wpt | COLICIN-E2 IMMUNITYPROTEIN (Escherichiacoli) | 3 / 3 | ARG A 42LEU A 43GLU A 45 | NO3 A1087 (-3.6A)NoneNone | 0.63A | 4l3gF-2wptA:undetectable | 4l3gF-2wptA:11.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_A_NOVA2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
3u2k | DNA GYRASE SUBUNIT B (Staphylococcusaureus) | 9 / 11 | ASN A 54SER A 55ASP A 57GLU A 58ASP A 81ARG A 84PRO A 87ARG A 144THR A 173 | 087 A 1 (-3.9A)087 A 1 (-3.3A) MG A 234 ( 4.8A)087 A 1 (-3.4A)087 A 1 (-3.5A)087 A 1 (-3.8A)087 A 1 (-4.3A)087 A 1 (-2.5A)087 A 1 ( 3.8A) | 0.66A | 4urnA-3u2kA:29.6 | 4urnA-3u2kA:50.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_A_NOVA2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
3u2k | DNA GYRASE SUBUNIT B (Staphylococcusaureus) | 9 / 11 | ASN A 54SER A 55GLU A 58ASP A 81ARG A 84PRO A 87ILE A 102ARG A 144THR A 173 | 087 A 1 (-3.9A)087 A 1 (-3.3A)087 A 1 (-3.4A)087 A 1 (-3.5A)087 A 1 (-3.8A)087 A 1 (-4.3A)None087 A 1 (-2.5A)087 A 1 ( 3.8A) | 0.65A | 4urnA-3u2kA:29.6 | 4urnA-3u2kA:50.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_B_NOVB2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
3u2k | DNA GYRASE SUBUNIT B (Staphylococcusaureus) | 10 / 11 | ASN A 54SER A 55ASP A 57GLU A 58ASP A 81ARG A 84PRO A 87ILE A 102ARG A 144THR A 173 | 087 A 1 (-3.9A)087 A 1 (-3.3A) MG A 234 ( 4.8A)087 A 1 (-3.4A)087 A 1 (-3.5A)087 A 1 (-3.8A)087 A 1 (-4.3A)None087 A 1 (-2.5A)087 A 1 ( 3.8A) | 0.56A | 4urnB-3u2kA:26.5 | 4urnB-3u2kA:50.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URN_C_NOVC2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
3u2k | DNA GYRASE SUBUNIT B (Staphylococcusaureus) | 10 / 11 | ASN A 54SER A 55ASP A 57GLU A 58ASP A 81ARG A 84PRO A 87ILE A 102ARG A 144THR A 173 | 087 A 1 (-3.9A)087 A 1 (-3.3A) MG A 234 ( 4.8A)087 A 1 (-3.4A)087 A 1 (-3.5A)087 A 1 (-3.8A)087 A 1 (-4.3A)None087 A 1 (-2.5A)087 A 1 ( 3.8A) | 0.53A | 4urnC-3u2kA:29.3 | 4urnC-3u2kA:50.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B) |
3u2k | DNA GYRASE SUBUNIT B (Staphylococcusaureus) | 6 / 12 | ASN A 54SER A 55ASP A 81ILE A 86GLN A 91ILE A 102 | 087 A 1 (-3.9A)087 A 1 (-3.3A)087 A 1 (-3.5A)087 A 1 (-4.4A)NoneNone | 1.12A | 4uroA-3u2kA:31.7 | 4uroA-3u2kA:84.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B) |
3u2k | DNA GYRASE SUBUNIT B (Staphylococcusaureus) | 10 / 12 | ASN A 54SER A 55GLU A 58ASP A 81ARG A 84ILE A 86PRO A 87ASP A 89ILE A 102ARG A 144 | 087 A 1 (-3.9A)087 A 1 (-3.3A)087 A 1 (-3.4A)087 A 1 (-3.5A)087 A 1 (-3.8A)087 A 1 (-4.4A)087 A 1 (-4.3A)NoneNone087 A 1 (-2.5A) | 0.36A | 4uroA-3u2kA:31.7 | 4uroA-3u2kA:84.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_B_NOVB2000_1 (DNA GYRASE SUBUNIT B) |
3u2k | DNA GYRASE SUBUNIT B (Staphylococcusaureus) | 6 / 12 | ASN A 54SER A 55ASP A 81ILE A 86GLN A 91ILE A 102 | 087 A 1 (-3.9A)087 A 1 (-3.3A)087 A 1 (-3.5A)087 A 1 (-4.4A)NoneNone | 1.18A | 4uroB-3u2kA:32.0 | 4uroB-3u2kA:84.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_B_NOVB2000_1 (DNA GYRASE SUBUNIT B) |
3u2k | DNA GYRASE SUBUNIT B (Staphylococcusaureus) | 10 / 12 | ASN A 54SER A 55GLU A 58ASP A 81ARG A 84ILE A 86PRO A 87ASP A 89ILE A 102ARG A 144 | 087 A 1 (-3.9A)087 A 1 (-3.3A)087 A 1 (-3.4A)087 A 1 (-3.5A)087 A 1 (-3.8A)087 A 1 (-4.4A)087 A 1 (-4.3A)NoneNone087 A 1 (-2.5A) | 0.32A | 4uroB-3u2kA:32.0 | 4uroB-3u2kA:84.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B) |
3u2k | DNA GYRASE SUBUNIT B (Staphylococcusaureus) | 10 / 12 | ASN A 54GLU A 58ASP A 81ARG A 84ILE A 86PRO A 87ASP A 89ALA A 98ILE A 102ARG A 144 | 087 A 1 (-3.9A)087 A 1 (-3.4A)087 A 1 (-3.5A)087 A 1 (-3.8A)087 A 1 (-4.4A)087 A 1 (-4.3A)NoneNoneNone087 A 1 (-2.5A) | 0.31A | 4uroC-3u2kA:32.0 | 4uroC-3u2kA:84.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B) |
3u2k | DNA GYRASE SUBUNIT B (Staphylococcusaureus) | 8 / 12 | ASN A 54GLU A 58ASP A 81ILE A 86PRO A 87GLN A 91ALA A 98ILE A 102 | 087 A 1 (-3.9A)087 A 1 (-3.4A)087 A 1 (-3.5A)087 A 1 (-4.4A)087 A 1 (-4.3A)NoneNoneNone | 0.98A | 4uroC-3u2kA:32.0 | 4uroC-3u2kA:84.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B) |
3u2k | DNA GYRASE SUBUNIT B (Staphylococcusaureus) | 11 / 12 | ASN A 54SER A 55GLU A 58ASP A 81ARG A 84ILE A 86PRO A 87ASP A 89ILE A 102ARG A 144THR A 173 | 087 A 1 (-3.9A)087 A 1 (-3.3A)087 A 1 (-3.4A)087 A 1 (-3.5A)087 A 1 (-3.8A)087 A 1 (-4.4A)087 A 1 (-4.3A)NoneNone087 A 1 (-2.5A)087 A 1 ( 3.8A) | 0.40A | 4uroD-3u2kA:31.3 | 4uroD-3u2kA:84.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CZM_D_HISD402_0 (ATPPHOSPHORIBOSYLTRANSFERASE CATALYTICSUBUNIT) |
1vq7 | 50S RIBOSOMALPROTEIN L30P (Haloarculamarismortui) | 4 / 8 | GLY W 124GLN W 137VAL W 29VAL W 128 | U 01096 ( 3.1A)None G 01087 ( 4.5A) A 01098 ( 3.7A) | 0.85A | 6czmD-1vq7W:undetectable6czmF-1vq7W:undetectable | 6czmD-1vq7W:19.946czmF-1vq7W:19.94 |